| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 37.45B | 36.72B | 45.71B | 45.58B | 43.81B |
| Gross Profit | 12.52B | 12.26B | 14.86B | 15.01B | 13.72B |
| EBITDA | 11.61B | 14.78B | 11.77B | 13.00B | 13.60B |
| Net Income | -4.17B | 1.14B | 11.84B | 2.24B | 59.00M |
Balance Sheet | |||||
| Total Assets | 128.52B | 144.35B | 155.52B | 154.05B | 155.06B |
| Cash, Cash Equivalents and Short-Term Investments | 15.49B | 10.53B | 18.48B | 14.73B | 11.87B |
| Total Debt | 53.14B | 54.36B | 61.50B | 67.18B | 66.80B |
| Total Liabilities | 74.61B | 83.35B | 91.04B | 96.98B | 97.25B |
| Stockholders Equity | 52.74B | 59.97B | 63.40B | 54.78B | 55.80B |
Cash Flow | |||||
| Free Cash Flow | 8.67B | 9.70B | 13.10B | 13.53B | 11.80B |
| Operating Cash Flow | 15.37B | 16.56B | 18.05B | 18.08B | 17.21B |
| Investing Cash Flow | 4.76B | -6.12B | -379.00M | -6.87B | -9.26B |
| Financing Cash Flow | -15.28B | -15.86B | -13.43B | -9.71B | -15.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $69.22B | 18.25 | 17.70% | 2.27% | 1.14% | 83.48% | |
73 Outperform | $230.74B | 19.84 | 19.03% | 1.72% | 7.30% | 17.67% | |
72 Outperform | $165.79B | 8.38 | 19.70% | 6.86% | 2.42% | 102.17% | |
72 Outperform | $173.27B | 7.94 | 20.88% | 4.52% | 1.98% | 150.68% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
54 Neutral | $27.02B | ― | -7.17% | 4.39% | 0.89% | -494.16% | |
49 Neutral | $24.19B | ― | -0.70% | 7.89% | -5.49% | -75.51% |